Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant
Clinical trial NCT01437709 · COMPLETED
Trial details
- NCT number
- NCT01437709
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2023-09-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.